Sign in to continue:

Wednesday, April 1st, 2026

Author: Minichart

us corporate news

FactSet Reports 7% Revenue Growth and 6.7% Organic ASV Increase in Q2 2026 Financial Results

Minichart
March 31, 2026

FactSet Reports Q2 2026 Results: Key Takeaways for Investors...

Continue Reading 0
us corporate news

T1 Energy Reports Record 2025 Results, Advances U.S. Solar Manufacturing and Secures $160M Tax Credit Sale

Minichart
March 31, 2026

T1 Energy Reports Q4 and Full-Year 2025 Results: Strong Oper...

Continue Reading 0
us corporate news

Atlantic Union Bankshares to Release Q1 2026 Financial Results and Host Investor Call April 21, 2026

Minichart
March 31, 2026

Key Highlights First Quarter 2026 Financial Results Rel...

Continue Reading 0
us corporate news

Iterum Therapeutics plc Receives Nasdaq Delisting Notice – Form 8-K Filing Details and Company Information

Minichart
March 31, 2026

Iterum Therapeutics plc Announces Delisting from Nasdaq and ...

Continue Reading 0
us corporate news

Telomir Pharmaceuticals Submits IND to FDA for Telomir-1 (Telomir-Zn) Targeting Advanced Triple-Negative Breast Cancer

Minichart
March 31, 2026

Telomir Pharmaceuticals, Inc. Submits IND for Telomir-1 (Tel...

Continue Reading 0
us corporate news

SCYNEXIS Acquires PXL-770 (SCY-770) to Advance Innovative ADPKD Therapy with Phase 2 Trial Planned for 2026

Minichart
March 31, 2026

SCYNEXIS Acquires PXL-770 (SCY-770) for ADPKD: Key Investor ...

Continue Reading 0
us corporate news

TD SYNNEX Reports Record Q1 2026 Results: Revenue Surges 18%, Non-GAAP EPS Up 69%, Raises Dividend

Minichart
March 31, 2026

TD SYNNEX Delivers Record Q1 FY2026 Results: Surging Revenue...

Continue Reading 0
us corporate news

SCYNEXIS Announces $40 Million Private Placement to Fund SCY-770 Development for Rare Kidney Disease

Minichart
March 31, 2026

SCYNEXIS Announces \$40 Million Private Placement to Advance...

Continue Reading 0
us corporate news

Xtant Medical Achieves Profitability and 14% Revenue Growth in 2025, Provides 2026 Outlook After Strategic Divestiture

Minichart
March 31, 2026

Xtant Medical (XTNT) Reports Q4 and Full-Year 2025 Financial...

Continue Reading 0
us corporate news

Tonix Pharmaceuticals Presents Phase 1 Data for TNX-4800, a Long-Acting Monoclonal Antibody for Lyme Disease Prevention, and Plans Adaptive Phase 2 Field Study

Minichart
March 31, 2026

Tonix Pharmaceuticals Announces Positive Phase 1 Data and Ph...

Continue Reading 0